We are excited to announce that we will be attending ISMPP EU 2026 in London, on 26–28 January. Please find information on our attendees, booth details and a summary of the research we will proudly be presenting at the conference below.
We will be located at Booth 10, where you’ll always be able to find a representative from Costello Medical and learn more about our company and services. We look forward to meeting with you! If you would like to book a meeting ahead of time, please feel free to reach out to any of the attendees listed below or
get in touch.
We are excited to have 9 attendees at ISMPP EU this year, including members of our Publications, Health Policy and Rare Diseases teams.
Medical Communications
Health Policy
Rare Diseases
The session will clarify the multimedia submission process by offering insights from two distinct perspectives and providing practical guidance for successful development, from budgeting considerations to practical recording tips. We will explore the differences between traditional and multimedia submissions while highlighting their fundamental similarities. Attendees will leave feeling confident in creating effective storyboards and discussion frameworks optimised for peer review evaluations, planning appropriate budgets and timelines, and apply good publications practices in these innovative formats.
This year we will be presenting 3 posters. The details of these can be found below:
How much time does AI really save in literature reviews? The emergence of generative AI models has sparked considerable interest in whether they could expedite the conduct of traditionally time- and resource-intensive literature reviews. At the same time, concerns about hallucinations and quality mean evidence synthesists approach AI with caution. Our poster presents the results of a systematic literature review to identify primary research studies reporting time or workload saved from applying AI to a literature review, compared with humans.
Is AI disclosure in publication development truly transparent? As use of, and guidance on, AI in medical writing evolves, evidence of disclosure remains limited. Our project examined AI use in the development of peer‑reviewed publications from major journals over a recent 6-month period, alongside feedback from publishers on the guidance they provide and perceptions of AI use during peer-review. By mapping current practices in AI use and disclosure, it aims to inform clearer, consistent disclosure standards for authors and editors and to strengthen trust in AI use in medical research.
The International Society for Medical Publication Professionals (ISMPP) Patient Engagement Task Force (PETF) was established to develop education and best practice guidance on partnering with patients and patient advocacy groups when creating medical publications and communications, and to build outreach with Patient Advocacy Groups to aid collaborations. The taskforce conducted an anonymous survey among ISMPP members to capture experiences and insights on patient engagement in medical publications, with the aim of identifying current challenges, key barriers, and actionable suggestions for enhancing patient involvement. Findings from this survey will guide ISMPP in developing targeted initiatives to promote, support, and advance patient engagement in future publication activities.
